Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
27 pending office actions • 17 clients • 27 examiners • 17 art units • 0 of 27 (0%) have an AI response strategy ready
Haukaas Fortius PLLC focuses on Biotechnology & Pharmaceuticals. The firm has handled 788 career applications and maintains a resolved allowance rate of 85.29 percent. Prosecution typically requires an average of 3.3 office actions per allowance.
There are 21 pending office actions currently under management. The 85.29 percent allowance rate and 3.3 average office actions per allowance provide a clear picture of the firm's prosecution history. With 788 career applications, the firm has established a consistent track record in the biotech arts. This historical data informs the firm's approach to the 21 pending office actions it is currently prosecuting. Practitioners can use the 85.29 percent allowance rate to understand the firm's success across its 788 career applications in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (7%) |
| §103 only | 5 (19%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 3 (11%) |
| Multi-statute (no §101) | 16 (59%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAO, SAVITHA M | 1 | 60.7% | +30.2% |
| SUN, CAITLYN MINGYUN | 1 | 63.5% | +11.9% |
| OLADAPO, TAIWO | 1 | 52.9% | +11.8% |
| TRAN, LIEN THUY | 1 | 28.6% | +26.5% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.7% |
| KIM, BOBBY YEONJIN | 1 | 76.6% | +21.2% |
| POTHEN, FEBA | 1 | 81.1% | +11.2% |
| NICKOL, GARY B | 1 | 47.1% | +31.1% |
| RITCHIE, HADEN MATTHEW | 1 | 73.4% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18300640 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | ZINGARELLI, SANDRA | 10d overdue |
| 17291169 | PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION | BAEK, BONG-SOOK | 2d overdue |
| 18633985 | PHOTOIONIZATION DETECTOR | POTHEN, FEBA | 13d |
| 18261373 | ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE | KIM, SEONG JONG | 21d |
| 18548580 | FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS | IVANOVA, SVETLANA M | 54d |
| 18914910 | TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY | SUN, CAITLYN MINGYUN | — |
| 18913376 | METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING | OLADAPO, TAIWO | — |
| 18838803 | COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL | TRAN, LIEN THUY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18633985 | PHOTOIONIZATION DETECTOR | POTHEN, FEBA | 13d |
| 19163760 | DRUG COMBINATION FOR TREATMENT OF PANCREATIC CANCER | RAO, SAVITHA M | — |
| 18914910 | TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY | SUN, CAITLYN MINGYUN | — |
| 18913376 | METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING | OLADAPO, TAIWO | — |
| 18838803 | COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL | TRAN, LIEN THUY | — |
| 18834350 | IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS | WHITE, DAWANNA SHAR-DAY | — |
| 18710813 | GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME | WILLIS, DOUGLAS M | — |
| 18708404 | BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK | KIM, BOBBY YEONJIN | — |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1618 | 2 |
| 1653 | 2 |
| 1691 | 1 |
| 3725 | 1 |
| 2858 | 1 |
| 3783 | 1 |
| 1777 | 1 |
| 1681 | 1 |
| 1636 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19163760 | DRUG COMBINATION FOR TREATMENT OF PANCREATIC CANCER | Minneamrita Therapeutics LLC | RAO, SAVITHA M | 1691 | §103 | Non-Final OA | — | Pending | Sep 09, 2025 |
| 18914910 | TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY | UNIVERSITY OF NOTRE DAME DU LAC | SUN, CAITLYN MINGYUN | §103§112 | Non-Final OA | — | Pending | Oct 14, 2024 | |
| 18913376 | METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING | Louisiana Tech Research Corporation | OLADAPO, TAIWO | §102§103 | Non-Final OA | — | Pending | Oct 11, 2024 | |
| 18838803 | COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL | Perfat Technologies OY | TRAN, LIEN THUY | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2024 | |
| 18834350 | IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS | The Board Of Trustees Of The University Of Illinois | WHITE, DAWANNA SHAR-DAY | §102§103DP | Non-Final OA | — | Pending | Jul 30, 2024 | |
| 18710813 | GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME | The Board Of Trustees Of The University Of Illinois | WILLIS, DOUGLAS M | §102§112 | Non-Final OA | — | Pending | May 16, 2024 | |
| 18708404 | BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK | Clb Entwicklungsgesellschaft Mbh | KIM, BOBBY YEONJIN | 3725 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18633985 | PHOTOIONIZATION DETECTOR | Alphasense Limited | POTHEN, FEBA | 2858 | §102§103§112 | Non-Final OA | 13d | Pending | Apr 12, 2024 |
| 18580889 | GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY | UNIVERSITY OF SOUTHERN CALIFORNIA | NICKOL, GARY B | §102§112DP | Non-Final OA | — | Pending | Jan 19, 2024 | |
| 18576658 | METHOD AND APPARATUS FOR A STEADY STATE INTRAMUSCULAR INFUSION OF SEROTONERGIC DRUGS | Psoulmed, LLC | RITCHIE, HADEN MATTHEW | 3783 | §103 | Final Rejection | — | Pending | Jan 04, 2024 |
| 18568609 | ELECTROCHEMICALLY-REGENERATED ION EXCHANGE USING REDOX-POLYMERS | The Board Of Trustees Of The University Of Illinois | KEYWORTH, PETER | 1777 | §102§103 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18503951 | CHEMICAL TOOLS FOR RNA 3D STRUCTURE DETERMINATION IN VIVO | Stichting Radboud Universiteit | RILEY, JEZIA | 1681 | §112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18493223 | THERAPEUTIC POLY-ADP-RIBOSE POLYMER-GCSF CONJUGATES | UNIVERSITY OF SOUTHERN CALIFORNIA | LAU, JONATHAN S | 1693 | §102§103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18382796 | REDOX-RESPONSIVE HALOGEN BONDING POLYMERS FOR SELECTIVE ELECTROCHEMICAL SEPARATION | The Board Of Trustees Of The University Of Illinois | JEBUTU, MOFOLUWASO SIMILOLUWA | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2023 | |
| 18550777 | CANCER THERAPY | National University Corporation Kobe University | CHONG, KIMBERLY | 1636 | §102§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18548580 | FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS | The Broad Institute, Inc. | IVANOVA, SVETLANA M | 1627 | §102§103§112 | Final Rejection | 54d | Pending | Sep 01, 2023 |
| 18546472 | CELL-FREE DNA METHYLATION TEST | UNIVERSITY OF SOUTHERN CALIFORNIA | JONES, CHRISTINE MICHELLE | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18263582 | ENZYME INHIBITORS AND VIRAL INFECTION THERAPY | UNIVERSITY OF SOUTHERN CALIFORNIA | VAJDA, KRISTIN ANN | 1622 | §102§112 | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18261373 | ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE | The Board Of Trustees Of The University Of Illinois | KIM, SEONG JONG | 1621 | §102§103 | Final Rejection | 21d | Pending | Jul 13, 2023 |
| 18253857 | SYNTHESIS OF [18F]-LABELED THYMIDINE ANALOGUES | UNIVERSITY OF SOUTHERN CALIFORNIA | BAEK, JONGHWAN NMN | 1618 | §103DP | Final Rejection | 15d | Pending | May 22, 2023 |
| 18320485 | NANO-HYPERBARIC WOUND HEALING THERAPEUTIC | Revive Biotechnology, Inc. | YU, HONG | 1614 | §103§112 | Final Rejection | — | Pending | May 19, 2023 |
| 18300640 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | Iowa State University Research Foundation, Inc. | ZINGARELLI, SANDRA | 1653 | §103§112 | Non-Final OA | 10d overdue | Pending | Apr 14, 2023 |
| 17996452 | CYCLODEXTRIN BASED ANTI-MICROBIAL THERAPY | UNIVERSITY OF SOUTHERN CALIFORNIA | CHO, DAVID H | 1693 | §103 | Non-Final OA | — | Pending | Oct 18, 2022 |
| 17626888 | SYNERGISTIC COMBINATION OF S-KETOROLAC AND PREGABALIN IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROPATHIC PAIN | Carlos Amezcua Amezcua | JUSTICE, GINA CHIEUN YU | 1617 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2022 |
| 17434217 | PASTE FOR MARKING TEXTILE FABRICS AND/OR OTHER PRODUCTS INCAPABLE OF X-RAY CONTRAST | Speed Care Mineral GmbH | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 3d overdue | Pending | Aug 26, 2021 |
| 17429299 | MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES | The Regents of the University of California | IANNUZO, NATALIE NMN | 1653 | §103 | Non-Final OA | 23d overdue | Pending | Aug 06, 2021 |
| 17291169 | PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION | Carlos Amezcua Amezcua | BAEK, BONG-SOOK | 1611 | §103§112 | Final Rejection | 2d overdue | Pending | May 04, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial